A Study of ALKS 5461 in Healthy Volunteers

NCT02068105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: ALKS 5461
DRUG: Placebo

Sponsor

Alkermes, Inc.